This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of cabergoline
PDMED_CABERGOLINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
587 |
4. Check minimum number of events
Min. number of events
3
|
587 |
5. Include endpointsNone |
587 |
6. Filter based on genotype QC (FinnGen only) |
534 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of cabergoline
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 534 | 311 | 223 |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | 0.10 |
| Median age at first event (years) | 46.77 | 39.14 | 57.41 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 546
- Matched controls
- 5460
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
247.7
307.7
230
16
E22.1
ICD-10 Finland
Hyperprolactinaemia
2805.6
307.7
371
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
878.5
307.7
308
8
N04BC06
ATC
cabergoline; oral
+∞
307.7
546
*
G02CB01
ATC
bromocriptine; systemic
50.9
217.4
129
33
G20
ICD-10 Finland
Parkinson disease
27.5
132.9
94
41
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
27.8
132.1
93
40
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
23.3
131.7
100
52
N04BD01
ATC
selegiline; oral
54.3
123.3
71
15
H02AB09
ATC
hydrocortisone; systemic
23.0
113.6
86
44
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
50.9
94.4
55
12
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
24.4
64.9
47
21
G02CB03
ATC
cabergoline; oral
78.8
56.5
63
9
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
7.3
54.7
88
140
N91.1
ICD-10 Finland
Secondary amenorrhoea
12.7
52.3
53
46
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
195.2
51.9
53
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
70.5
50.3
57
9
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
187.1
49.8
51
*
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
45.5
43
*
N04BC05
ATC
pramipexole; oral
5.9
44.8
90
178
N04BX02
ATC
entacapone; oral
232.9
42.5
43
*
E23.00
ICD-10 Finland
Panhypopituitarism
155.2
41.4
43
*
N04BC04
ATC
ropinirole; oral
63.1
35.7
41
7
XCK00
NOMESCO Finland
Perimetry
5.4
29.4
62
127
N87
ICPC
Parkinsonism
31.3
28.9
38
13
N04BD02
ATC
rasagiline; oral
51.6
28.7
34
7
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
67.8
28.2
32
5
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
295.9
28.0
28
*
H03AA01
ATC
levothyroxine sodium; systemic
2.9
26.3
170
746
193
Kela drug reimbursment
Rasagiline
50.9
24.5
29
6
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
250.5
23.8
24
*
G02CB04
ATC
quinagolide; oral
+∞
23.1
22
*
N04AA02
ATC
biperiden; systemic
8.2
21.5
29
37
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.9
20.7
38
68
N03AE01
ATC
clonazepam; systemic
4.5
20.3
52
125
N06DA03
ATC
rivastigmine; oral, transdermal
5.5
19.2
38
73
N04BC01
ATC
bromocriptine; oral
+∞
17.8
17
*
N04BB01
ATC
amantadine; oral
15.5
17.3
28
19
D352, E221,
ICD-10 Finland
+∞
16.7
16
*
N04BC02
ATC
pergolide; oral
+∞
15.7
15
*
G03DB01
ATC
dydrogesterone; oral
2.8
14.9
86
347
E23.05
ICD-10 Finland
Lack of TSH
51.3
12.9
15
*
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
132.9
12.5
13
*
H01CB02
ATC
octreotide; parenteral
38.5
12.3
15
*
ZXC86
NOMESCO Finland
Use of endoscopic device
38.5
12.3
15
*
H01CB03
ATC
lanreotide; parenteral
30.8
11.7
15
5
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
11.5
11
*
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
+∞
10.4
10
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.3
10.3
27
66
H02AA02
ATC
fludrocortisone; oral
12.5
9.9
17
14
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
30.6
9.4
12
*
2542
FHL
Transasal hypophysectomy
+∞
9.4
9
*
N04BC09
ATC
rotigotine; transdermal
24.5
8.9
12
5
E23.6
ICD-10 Finland
Other disorders of pituitary gland
91.4
8.4
9
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
8.1
8.4
18
23
H53.4
ICD-10 Finland
Visual field defects
4.8
8.4
19
41
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.6
8.3
49
199
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
17.5
8.1
12
7
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
22.4
8.0
11
5
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
7.8
76
385
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
7.3
7
*
N04AA01
ATC
trihexyphenidyl; oral
+∞
7.3
7
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
7.3
98
558
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.9
7.1
14
16
102
Kela drug reimbursment
Diabetes insipidus
40.6
6.8
8
*
N64.3
ICD-10 Finland
Galactorrhoea not associated with childbirth
12.4
6.6
11
9
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.5
6.5
22
65
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
70.6
6.4
7
*
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
70.6
6.4
7
*
E23.08
ICD-10 Finland
Hypopituitarism
+∞
6.3
6
*
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
6.3
6
*
E21.0
ICD-10 Finland
Primary hyperparathyroidism
5.4
6.2
17
32
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
340
272
31.48
307.65
8.7
1.4
533.93
286.40
mu/l
2.51
329
250
323
472
15.31
240.13
5.3
2.0
368.88
383.40
nmol/l
0.65
317
444
188
203
13.60
167.51
2.0
1.3
6.15
9.19
u/l
2.09
151
167
91
38
28.54
130.65
2.1
1.4
45.63
31.07
ng/l
0.43
91
38
102
77
16.06
111.35
8.1
1.2
779.22
345.63
mu/l
1.12
95
63
174
435
5.40
68.35
7.0
2.4
11.11
13.13
nmol/l
2.80
168
405
154
356
5.63
65.96
1.9
1.4
13.16
22.02
iu/l
3.63
122
309
92
128
8.44
64.71
1.8
1.5
0.33
0.37
nmol/l
0.21
73
106
47
8
64.07
40.96
2.0
1.4
1.06
—
nmol/l
—
5
0
455
3577
2.63
16.37
8.0
4.4
14.74
14.56
pmol/l
0.84
443
3319
24
44
5.66
12.69
1.3
1.1
—
—
—
0
0
267
1845
1.88
11.60
6.7
6.5
1.22
1.21
mmol/l
0.72
254
1720
290
2070
1.86
11.25
8.0
7.2
1.22
1.21
mmol/l
0.44
252
1813
23
46
5.18
11.09
6.2
3.5
4.88
6.96
nmol/l
0.22
23
46
16
15
10.95
8.84
2.8
1.2
98.38
76.87
nmol/24h
0.33
16
15
466
4219
1.71
4.75
7.9
5.3
1.66
1.82
mu/l
2.83
444
3971
53
290
1.92
4.43
6.1
4.1
96.86
85.60
ng/l
0.23
46
263
14
38
3.75
3.82
3.1
2.4
18.60
18.59
mu/l
0.00
14
38
11
25
4.47
3.64
1.6
1.6
—
—
—
0
0
237
2007
1.32
2.59
3.1
2.5
74.29
73.64
nmol/l
0.14
226
1844
62
416
1.55
2.56
3.2
3.1
—
—
—
0
0
7
193
0.35
2.44
1.3
1.4
—
—
—
0
0
7
17
4.16
2.36
2.1
1.3
53.86
66.39
ug/l
—
7
17
52
349
1.54
2.17
2.8
2.3
6418.85
5480.74
u/l
0.08
18
153
13
56
2.35
2.06
1.5
1.3
—
—
—
0
0
455
4289
1.37
1.98
15.5
13.3
87.54
87.56
ml/min/173m2
0.01
432
3917
150
1232
1.30
1.96
3.4
3.0
0.34
0.33
e6/l
0.01
111
897
12
252
0.46
1.93
2.2
1.7
0.08
0.33
mg/l
—
7
110
216
1869
1.26
1.84
2.1
2.0
93.77
96.18
pmol/l
0.33
123
1025
68
901
0.72
1.77
1.3
1.3
23.69
25.34
iu/ml
0.07
16
269
212
1838
1.25
1.76
1.8
1.9
1.39
1.36
mmol/l
0.15
189
1603
289
2596
1.24
1.73
5.1
4.9
6.19
6.54
mmol/l
3.16
278
2405
146
1214
1.28
1.72
1.6
1.6
18.74
19.91
nmol/l
0.46
130
1054
364
3362
1.25
1.66
7.2
8.2
71.71
75.48
u/l
1.63
348
3200
63
835
0.72
1.65
1.2
1.3
5.86
6.44
u/ml
0.05
27
330
20
334
0.58
1.59
2.5
2.4
—
16.74
—
0
39
88
693
1.32
1.56
2.9
2.9
2.84
2.63
e6/l
0.09
51
332
89
1095
0.78
1.39
3.4
3.6
1.02
1.02
kg/l
0.69
59
741
24
368
0.64
1.37
3.3
4.8
2.44
26.73
ug/l
1.11
16
299
5
17
2.96
1.36
1.6
1.9
1.44
0.85
nmol/l
—
5
11
12
61
1.99
1.33
1.3
1.3
0.57
0.53
nmol/l
0.27
12
55
167
1450
1.22
1.31
3.4
3.1
88.58
92.42
e6/l
0.02
128
1096
29
423
0.67
1.31
6.9
6.8
—
—
—
0
0
11
203
0.53
1.27
1.5
2.0
—
—
—
0
0
6
26
2.32
1.19
1.8
2.3
438.33
715.04
u/ml
—
6
26
6
128
0.46
1.18
1.0
1.2
—
53.51
—
0
14
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
27
183
1.50
1.15
1.7
1.7
—
—
—
0
0
116
985
1.23
1.13
2.8
2.6
8.00
6.79
e6/l
0.32
103
895
7
31
2.27
1.10
1.0
1.6
0.47
0.46
e9/l
—
7
31
168
1486
1.19
1.07
2.8
3.0
0.05
0.08
estimate
0.17
59
451
42
315
1.36
1.07
2.2
2.4
71.74
70.66
ml/min/173m2
0.07
21
137
61
484
1.29
1.06
5.2
4.3
32.57
31.04
%
0.57
53
342
20
130
1.56
1.04
1.6
1.4
254.27
286.72
ug/g
0.37
15
70
7
34
2.07
1.03
1.0
1.5
79.29
74.53
umol/l
—
7
34
33
240
1.40
1.01
3.6
2.7
1.80
1.56
mmol/l
0.17
26
172
14
84
1.68
0.98
2.9
2.9
7.30
9.78
pmol/l
0.68
14
84
13
210
0.61
0.97
3.1
3.7
49.14
48.94
%
0.01
13
204
38
495
0.75
0.94
1.9
2.0
—
—
—
0
0
50
397
1.29
0.89
1.3
1.3
95.17
150.31
u/ml
0.69
16
163
24
331
0.71
0.86
1.3
1.5
—
—
—
0
0
12
191
0.62
0.86
1.7
3.4
24.07
24.64
mmol/l
0.22
12
183
427
4109
1.18
0.85
6.0
5.7
37.61
38.56
mmol/mol
1.65
412
3911
155
1387
1.16
0.85
2.3
2.7
55.27
61.41
u/l
0.57
143
1307
30
223
1.37
0.83
1.4
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
3.1
—
0.88
—
0
24
11
66
1.68
0.79
1.2
1.2
17.70
21.03
u/l
0.22
11
60
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
202
2192
0.88
0.78
2.9
2.8
—
—
estimate
—
0
0
16
231
0.68
0.75
1.6
1.7
—
—
—
0
0
9
54
1.68
0.75
1.7
1.1
—
—
—
0
0
85
734
1.19
0.72
3.0
2.7
0.79
0.83
e6/l
0.04
48
369
12
76
1.59
0.72
2.3
2.0
13.67
13.10
%
0.88
12
76
10
157
0.63
0.70
1.1
1.2
—
2.35
—
0
6
20
144
1.40
0.69
1.4
2.3
1.57
4.74
iu/l
2.91
12
66
5
27
1.86
0.68
1.8
1.3
—
—
—
0
0
77
664
1.19
0.67
1.7
1.7
1135.31
1155.56
nmol/l
0.07
62
510
116
1294
0.87
0.67
4.6
4.2
4.00
10.58
mg/mmol
3.31
71
855
5
28
1.79
0.66
1.4
1.3
—
—
—
0
0
12
78
1.55
0.66
1.9
1.4
—
—
—
0
0
19
137
1.40
0.65
1.4
2.0
283.26
340.39
ug/l
0.13
19
131
198
1834
1.12
0.65
4.7
5.4
35.86
36.42
g/l
0.80
187
1740
158
1444
1.13
0.64
3.0
3.4
2.33
2.34
mmol/l
0.70
144
1320
144
1311
1.13
0.62
5.4
5.0
1.55
2.47
ug/l
1.99
128
1191
464
4743
0.86
0.62
11.4
11.1
25.47
26.29
u/l
0.44
451
4642
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
39.22
—
0
11
0
21
0.00
0.60
0.0
1.0
—
562.77
—
0
13
432
4434
0.88
0.59
5.1
4.6
4.61
4.63
mmol/l
0.15
419
4223
437
4481
0.88
0.58
5.5
5.0
2.77
2.74
mmol/l
0.31
425
4252
6
35
1.72
0.58
1.8
1.4
—
—
—
0
0
200
1872
1.11
0.53
12.9
12.3
1.17
1.21
inr
0.57
178
1557
26
205
1.28
0.53
1.6
1.3
—
—
—
0
0
52
605
0.84
0.52
2.0
2.2
—
—
—
0
0
22
170
1.31
0.52
1.5
1.6
—
—
—
0
0
31
253
1.24
0.49
8.0
9.1
24.48
24.41
mmol/l
0.05
31
247
55
477
1.17
0.48
5.2
4.7
206.91
242.17
u/l
3.21
55
457
30
364
0.81
0.47
2.3
2.5
0.32
0.45
e6/l
0.19
30
346
432
4417
0.89
0.46
5.0
4.5
1.41
1.44
mmol/l
1.15
421
4184
16
120
1.34
0.46
1.6
1.2
—
—
—
0
0
8
120
0.66
0.46
1.4
1.5
—
—
—
0
0
25
307
0.81
0.45
2.1
2.4
12.58
8.11
ug/l
0.27
20
280
72
642
1.14
0.44
2.0
2.1
29.79
29.37
s
0.19
72
630
104
1136
0.90
0.44
2.6
2.7
335.37
334.30
umol/l
0.04
91
1022
78
866
0.88
0.44
1.8
1.7
443.96
26455459.19
pmol/l
0.79
67
756
9
127
0.70
0.44
3.8
1.7
—
—
—
0
0
16
122
1.32
0.42
3.3
3.4
2.63
2.38
index
—
8
71
13
173
0.75
0.42
1.2
1.6
1.42
1.18
g/l
1.79
13
164
6
93
0.64
0.42
1.5
1.8
—
—
—
0
0
6
95
0.63
0.42
1.0
1.1
—
—
—
0
0
50
436
1.16
0.42
6.3
8.8
0.71
0.85
mmol/l
0.11
36
359
8
58
1.38
0.41
1.1
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
4.1
—
4.52
—
0
16
0
16
0.00
0.41
0.0
4.1
—
11.09
—
0
16
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
8
61
1.32
0.39
2.1
1.4
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
18
225
0.79
0.38
1.2
1.1
0.82
0.88
g/l
0.75
18
225
5
36
1.39
0.38
3.0
2.3
—
—
—
0
0
82
899
0.90
0.38
1.7
1.5
—
—
—
0
0
259
2487
1.08
0.37
3.5
3.6
0.00
0.00
estimate
0.50
66
549
120
1118
1.09
0.36
2.6
2.2
—
—
—
0
0
77
702
1.11
0.35
2.1
1.9
—
—
—
0
0
41
359
1.15
0.34
5.9
7.7
8.77
8.81
mmol/l
0.01
41
344
44
497
0.88
0.33
1.5
1.6
985.90
991.55
mu/l
0.02
39
423
6
46
1.31
0.33
1.0
1.1
—
72.20
—
0
5
18
220
0.81
0.33
1.2
1.1
1.60
1.54
g/l
0.38
18
220
6
90
0.66
0.33
1.8
1.5
—
—
—
0
0
14
110
1.28
0.32
2.2
1.4
403.57
430.26
mg/l
0.22
14
104
7
52
1.35
0.31
1.4
1.1
—
—
—
0
0
85
785
1.10
0.31
2.9
3.0
0.72
0.79
ug/l
0.41
52
473
259
2502
1.07
0.30
3.4
3.6
21.90
5.69
estimate
0.33
68
550
56
507
1.12
0.30
1.7
1.9
—
—
—
0
0
36
408
0.87
0.29
3.7
3.5
5.93
5.73
kpa
0.94
36
393
17
206
0.82
0.29
1.5
1.7
—
—
—
0
0
8
109
0.73
0.29
1.6
1.5
—
—
—
0
0
109
1160
0.92
0.28
1.8
1.7
—
—
—
0
0
106
1129
0.92
0.28
3.3
3.3
989.96
1195.58
ng/l
0.39
91
941
8
62
1.29
0.28
2.1
1.4
—
—
—
0
0
8
62
1.29
0.28
2.1
1.4
—
—
—
0
0
87
810
1.09
0.27
3.1
3.6
770.82
341.53
ng/l
0.25
61
557
15
122
1.24
0.27
2.5
1.5
—
—
—
0
0
101
1071
0.93
0.25
1.6
1.8
1.02
1.15
mg/l
0.20
76
814
111
1050
1.07
0.24
3.7
4.3
25.34
21.99
%
1.38
51
476
254
2466
1.06
0.24
3.5
3.2
92.64
106.04
ug/l
0.65
241
2345
7
95
0.73
0.22
1.7
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
10
80
1.25
0.20
1.4
1.4
—
—
—
0
0
10
80
1.25
0.20
1.4
1.4
—
—
—
0
0
58
539
1.09
0.20
2.0
2.9
4.13
7.65
umol/l
4.39
48
472
6
48
1.25
0.20
1.2
1.2
—
—
—
0
0
25
281
0.88
0.20
1.1
1.0
—
—
—
0
0
6
51
1.18
0.19
1.0
1.9
—
—
—
0
0
260
2661
0.96
0.19
8.3
9.7
3.99
4.06
e9/l
0.21
235
2341
7
60
1.17
0.18
2.3
1.4
—
—
—
0
0
7
60
1.17
0.18
2.3
1.4
—
—
—
0
0
7
61
1.15
0.17
7.1
5.6
345.86
352.29
umol/l
—
7
56
7
61
1.15
0.17
2.3
1.4
—
—
—
0
0
125
1202
1.05
0.17
2.6
2.1
2.63
2.70
mg/l
0.15
106
1055
11
131
0.84
0.17
1.2
1.2
—
—
—
0
0
7
63
1.11
0.17
2.0
1.5
—
—
—
0
0
5
67
0.74
0.17
1.4
1.2
—
—
—
0
0
24
265
0.90
0.15
1.4
1.5
1.17
1.22
ratio
0.15
16
171
24
265
0.90
0.15
1.4
1.5
0.84
0.93
ratio
0.96
16
171
24
265
0.90
0.15
1.4
1.5
1.07
1.20
ratio
0.32
16
171
161
1657
0.96
0.15
2.8
3.4
31.04
30.73
u/l
0.02
152
1588
227
2319
0.96
0.14
5.8
6.6
9.57
11.40
umol/l
3.30
215
2217
258
2531
1.04
0.14
3.5
3.6
0.00
0.58
estimate
0.50
63
518
87
907
0.95
0.14
2.2
2.1
—
—
—
0
0
420
4240
0.96
0.13
5.1
4.5
5.70
5.82
mmol/l
1.52
400
3977
94
977
0.95
0.13
2.3
2.3
—
—
—
0
0
24
263
0.91
0.13
1.4
1.5
—
—
—
0
0
17
151
1.13
0.13
1.8
1.8
—
—
—
0
0
12
138
0.87
0.13
1.3
2.7
—
—
—
0
0
12
104
1.16
0.12
1.5
1.3
—
—
—
0
0
14
158
0.88
0.12
1.2
1.3
—
—
—
0
0
18
162
1.11
0.12
2.9
2.0
—
—
—
0
0
39
367
1.07
0.11
7.6
7.2
1.19
1.24
mmol/l
0.19
39
360
29
311
0.93
0.11
1.7
1.6
—
—
—
0
0
26
241
1.08
0.10
1.5
1.5
—
—
—
0
0
416
4193
0.97
0.10
4.4
3.9
1.29
1.26
mmol/l
0.35
399
3949
141
1443
0.97
0.10
3.4
3.4
8.41
8.14
mmol/l
0.21
131
1246
16
176
0.91
0.09
1.3
1.6
64.02
55.09
ug/l
0.35
16
176
11
124
0.88
0.09
2.9
1.6
—
—
—
0
0
140
1371
1.03
0.08
3.5
3.6
0.03
0.01
estimate
0.33
67
513
125
1224
1.03
0.08
1.3
1.3
1.44
2.07
u/ml
0.41
37
356
6
72
0.83
0.07
1.2
2.2
—
1552.00
—
0
5
6
72
0.83
0.07
1.0
1.1
—
1.68
—
0
6
6
74
0.81
0.07
1.8
1.6
—
—
—
0
0
160
1626
0.98
0.07
3.1
3.6
23.14
38.72
ng/l
1.92
100
1027
8
91
0.88
0.07
1.3
1.2
—
—
—
0
0
78
800
0.97
0.06
2.4
2.8
2.44
2.43
mmol/l
0.52
65
707
31
325
0.95
0.06
1.5
1.4
—
—
—
0
0
338
3355
1.02
0.06
4.0
4.2
9.75
10.36
mm/h
0.42
325
3158
61
628
0.97
0.06
1.8
1.9
3.50
3.52
ratio
0.05
52
477
11
100
1.10
0.05
3.0
1.6
0.80
0.90
nmol/l
0.25
11
89
196
1941
1.02
0.04
3.3
3.4
0.05
0.04
estimate
0.12
56
472
328
3298
0.99
0.04
3.4
3.3
38.02
42.78
u/l
0.80
315
3162
17
161
1.06
0.03
1.9
2.3
3.97
3.58
g/l
0.61
17
156
24
248
0.97
0.02
1.4
1.4
332.15
239.47
miu/ml
0.55
13
132
334
3351
0.99
0.02
3.5
3.6
—
—
—
0
0
28
287
0.97
0.01
1.3
1.4
—
—
—
0
0
47
477
0.98
0.01
1.4
1.7
3.31
3.46
mmol/l
0.35
37
333
14
145
0.96
0.00
1.2
1.2
—
—
—
0
0
14
145
0.96
0.00
1.7
1.3
—
—
—
0
0
14
144
0.97
0.00
1.2
1.2
—
—
—
0
0
49
485
1.01
0.00
1.8
1.9
—
—
—
0
0
455
4555
0.99
0.00
14.6
14.6
23.02
22.40
mg/l
0.16
376
3722
10
99
1.01
0.00
1.1
1.2
—
—
—
0
0
497
4972
1.00
0.00
25.0
22.0
4.55
4.53
e12/l
0.36
492
4892
497
4969
1.00
0.00
25.1
22.0
253.77
252.78
e9/l
0.14
492
4902
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
10.4
—
5.96
—
0
5
0
5
0.00
0.00
0.0
10.4
—
10.06
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
8
83
0.96
-0.00
3.9
1.7
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
1.18
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
1.27
—
0
7
44
440
1.00
-0.00
2.2
2.5
26.61
30.56
u/l
0.94
36
367
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.8
1.5
—
—
—
0
0
8
89
0.90
-0.00
1.6
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
11
110
1.00
-0.00
5.1
4.4
34.26
2.52
ratio
—
6
59
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_CABERGOLINE – Use of cabergoline
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).